Table 2 . Susceptibility of isolates of Candida to antifungal drugs .

	Susceptibility	C. albicans	C. glabrata	C. krusei	Total
Amphotericine B	Resistance	0(0.0%)	0(0.0%)	0(0.0%)	0(0.0%)
	Dose dependent	4(19.0%)	8(38.1%)	1(4.8%)	13(61.9%)
	Sensitive	7(33.3%)	1(4.8%)	0(0.0%)	8(38.1%)
	Total	11(52.3%)	9(42.9%)	1(4.8%)	21(100%)
Nystatin	Resistance	0(0.0%)	1(4.8%)	0(0.0%)	1(4.8%)
	Dose dependent	0(0.0%)	8(38.1%)	1(4.8%)	9(42.9%)
	Sensitive	11(52.3%)	0(0.0%)	0(0.0%)	11(52.3%)
	Total	11(52.3%)	9(42.9%)	1(4.8%)	21(100%)
Ketoconazole	Resistance	7(33.3%)	0(0.0%)	0(0.0%)	7(33.3%)
	Dose dependent	3(14.3%)	3(14.3%)	0(0.0%)	6(28.6%)
	Sensitive	1(4.8%)	6(28.6%)	1(4.8%)	8(38.1%)
	Total	11(52.3%)	9(42.9%)	1(4.8%)	21(100%)
Clotrimazole	Resistance	0(0.0%)	0(0.0%)	0(0.0%)	0(0.0%)
	Dose dependent	5(23.8%)	2(9.5%)	0(0.0%)	7(33.3%)
	Sensitive	6(28.6%)	7(33.3%)	1(4.8%)	14(66.7%)
	Total	11(52.3%)	9(42.9%)	1(4.8%)	21(100%)
Miconazole	Resistance	0(0.0%)	0(0.0%)	0(0.0%)	0(0.0%)
	Dose dependent	3(14.3%)	0(0.0%)	0(0.0%)	3(14.3%)
	Sensitive	8(38.1%)	9(42.9%)	1(4.8%)	18(85.7%)
	Total	11(52.3%)	9(42.9%)	1(4.8%)	21(100%)